DxDiscovery
About:
DxDiscovery is a biotechnology research and development firm.
Website: http://www.dxdiscovery.com/
Top Investors: U.S. Department of Health & Human Services
Description:
DxDiscovery is a research and development company for biotechnology. The creation of moderate, microbial monoclonal antibody antibodies is the corporate objective. These antibodies may be created as preventatives or treatments for infectious diseases, or they may be used in quick POC diagnostics. Products in their diagnostics portfolio will help in circumstances when the existing treatment protocol is time-consuming or very likely to yield erroneous results.
$600000
Less than $1M
Reno, Nevada, United States
2012-01-01
info(AT)dxdiscovery.com
David AuCoin, Thomas Kozel
11-50
2013-08-02
Private
© 2025 bioDAO.ai